Interferon-alpha response in chronic hepatitis B-transfected HepG2.2.15 cells is partially restored by lamivudine treatment.
OBJECTIVE
To characterize the IFN-response and its modulation by the antiviral compound lamivudine in HBV-transfected HepG2.2.15 cells.


METHODS
HepG2.2.15 and HepG2 cells were stimulated with various concentrations of IFN-alpha2a in the presence or absence of lamivudine. Then, total RNA was extracted and analysed by customised cDNA arrays and northern blot for interferon-inducible genes (ISGs). In addition, cellular proteins were extracted for EMSA and western blot. HBV replication was assessed by southern blot or ELISAs for HBsAg and HBeAg.


RESULTS
Two genes (MxA, Cig5) with completely abolished and 4 genes (IFITM1, -2, -3, and 6-16) with partially reduced IFN-responses were identified in HepG2.2.15 cells. In 2 genes (IFITM1, 6-16), the response to IFN-alpha could be restored by treatment with lamivudine. This effect could not be explained by a direct modulation of the Jak/Stat signalling pathway since EMSA and western blot experiments revealed no suppression of Stat1 activation and ISGF3 formation after stimulation with IFN-alpha in HepG2.2.15 compared to HepG2 cells.


CONCLUSIONS
These results are consistent with the assumption that chronic hepatitis B may specifically modulate the cellular response to IFN by a selective blockage of some ISGs. Antiviral treatment with lamivudine may partially restore ISG expression by reducing HBV gene expression and replication.
Guan
Shi-He
SH
Department of Gastroenterology and Hepatology, University Hospital of Essen, Hufelandstr. 55, Essen 45122, Germany.
Lu
Mengji
M
Grünewald
Petra
P
Roggendorf
Michael
M
Gerken
Guido
G
Schlaak
Jörg F
JF
D019380:Anti-HIV Agents / Q000494:pharmacology*; D002478:Cells, Cultured; D020869:Gene Expression Profiling; D015967:Gene Expression Regulation, Viral / Q000187:drug effects*; D006515:Hepatitis B virus / Q000187:drug effects* / Q000235:genetics*; D006801:Humans; D016898:Interferon-alpha / Q000378:metabolism / Q000494:pharmacology*; D019259:Lamivudine / Q000494:pharmacology*; D020411:Oligonucleotide Array Sequence Analysis; D014176:Protein Biosynthesis / Q000187:drug effects / Q000235:genetics; D014162:Transfection; D014764:Viral Proteins / Q000235:genetics; D014779:Virus Replication / Q000187:drug effects
D019380:Anti-HIV Agents; D016898:Interferon-alpha; D014764:Viral Proteins; D019259:Lamivudine